A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants

NCT06081699 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: TNP-2198
DRUG: TNP-2198 Placebo

Sponsor

TenNor Therapeutics (Suzhou) Limited